Krause, A <br/><br/>
Population Modeling of Selexipag Pharmacokinetics and Clinical Response Parameters in Patients With Pulmonary Arterial Hypertension.  [electronic resource] 

 -  CPT: pharmacometrics & systems pharmacology  07 2017 
 - 477-485 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2163-8306 
<br/><br/><label>Standard No.: </label>10.1002/psp4.12202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--adverse effects<br/>Acetates--blood<br/>Adult<br/>Antihypertensive Agents--adverse effects<br/>Bilirubin--blood<br/>Double-Blind Method<br/>Exercise Tolerance--drug effects<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--blood<br/>Leukocyte Count<br/>Male<br/>Models, Biological<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Pyrazines--adverse effects<br/>Treatment Outcome